Sotera Health Announces Third-Quarter 2025 Earnings Release Date
Sotera Health (Nasdaq: SHC) will release third-quarter 2025 financial results for the period ended September 30, 2025 before the market opens on Tuesday, November 4, 2025.
Management will host a conference call at 9:00 a.m. Eastern Daylight Time the same day to discuss results and operating highlights. Participants may dial 1-844-481-2916 (U.S. toll-free) or 1-412-317-0709 from other locations. A live webcast and accompanying materials will be available via the company’s Investor Relations Presentation & Events page, and a replay of the webcast will be posted later on November 4.
Sotera Health (Nasdaq: SHC) pubblicherà i risultati finanziari del terzo trimestre 2025 per il periodo terminato 30 settembre 2025 prima dell'apertura del mercato martedì 4 novembre 2025.
La direzione terrà una conferenza telefonica alle 9:00 a.m. ora legale orientale lo stesso giorno per discutere i risultati e i punti salienti operativi. I partecipanti possono chiamare lo 1-844-481-2916 (numero gratuito USA) o lo 1-412-317-0709 da altre località. Una trasmissione in diretta e i materiali accompagnatori saranno disponibili tramite la pagina Investor Relations Presentation & Events dell'azienda, e una riproduzione della trasmissione sarà pubblicata più tardi il 4 novembre.
Sotera Health (Nasdaq: SHC) divulgará los resultados financieros del tercer trimestre de 2025 para el periodo terminado el 30 de septiembre de 2025 antes de la apertura del mercado el martes 4 de noviembre de 2025.
La dirección llevará a cabo una conferencia telefónica a las 9:00 a.m. hora del Este ese mismo día para discutir los resultados y los aspectos operativos destacados. Los participantes pueden marcar el 1-844-481-2916 (número gratuito de EE. UU.) o el 1-412-317-0709 desde otras ubicaciones. Una transmisión en vivo y los materiales acompañantes estarán disponibles a través de la página de Investor Relations Presentation & Events de la empresa, y una grabación de la transmisión estará disponible más tarde el 4 de noviembre.
Sotera Health (Nasdaq: SHC)는 2025년 9월 30일로 종료되는 2025년 3분기 재무 실적을 2025년 11월 4일 화요일에 시가 개장 전 발표합니다.
경영진은 같은 날 동부 일광 시간으로 오전 9:00에 컨퍼런스 콜을 주최하여 실적과 운영 하이라이트를 논의합니다. 참가자는 미국 내 무료 전화번호 1-844-481-2916 또는 다른 지역에서 1-412-317-0709로 전화하실 수 있습니다. 생방송 웹캐스트 및 동반 자료는 회사의 투자자 관계 페이지의 Presentation & Events에서 이용 가능하며, 웹캐스트 재방송은 11월 4일에 게시될 예정입니다.
Sotera Health (Nasdaq : SHC) publiera les résultats financiers du troisième trimestre 2025 pour la période se terminant le 30 septembre 2025 avant l'ouverture du marché le mardi 4 novembre 2025.
La direction organisera une conférence téléphonique à 9h00, heure avancée de l’Est le même jour pour discuter des résultats et des points opérationnels clés. Les participants peuvent composer le 1-844-481-2916 (numéro vert américain) ou le 1-412-317-0709 depuis d'autres lieux. Une présentation en direct et les documents qui l'accompagnent seront disponibles via la page Investor Relations Presentation & Events de l'entreprise, et une rediffusion de la conférence sera publiée plus tard le 4 novembre.
Sotera Health (Nasdaq: SHC) wird die Finanzergebnisse des dritten Quartals 2025 für den Zeitraum bis zum 30. September 2025 vor der Markteröffnung am Dienstag, dem 4. November 2025, veröffentlichen.
Die Geschäftsführung wird am selben Tag um 9:00 Uhr Eastern Daylight Time eine Telefonkonferenz abhalten, um Ergebnisse und operative Highlights zu erläutern. Die Teilnehmer können die Nummer 1-844-481-2916 (US gebührenfrei) oder 1-412-317-0709 von anderen Standorten wählen. Eine Live-Webcast und begleitende Unterlagen werden über die Investor Relations-Seite des Unternehmens, Presentation & Events, verfügbar sein, und eine Wiedergabe des Webcasts wird später am 4. November veröffentlicht.
Sotera Health (Nasdaq: SHC) ستصدر نتائجها المالية للربع الثالث من 2025 للفترة المنتهية في 30 سبتمبر 2025 قبل فتح السوق في الثلاثاء 4 نوفمبر 2025. ستعقد الإدارة مكالمة مؤتمرات هاتفية في 9:00 صباحاً بتوقيت الساحل الشرقي الصيفي في اليوم نفسه لمناقشة النتائج والنقاط التشغيلية البارزة. يمكن للمشاركين الاتصال على الرقم 1-844-481-2916 (خط أمريكي مجاني) أو 1-412-317-0709 من مواقع أخرى. ستكون هناك بث مباشر عبر الإنترنت ومواد مرفقة متاحة من خلال صفحة علاقات المستثمرين Presentation & Events التابعة للشركة، وسيتم وضع إعادة للبث لاحقاً في 4 نوفمبر.
Sotera Health (Nasdaq: SHC) 将在2025年11月4日周二股市开盘前发布截至2025年9月30日的2025年第三季度财务业绩。管理层将于同日举行电话会议，时间为 美国东部夏令时上午9:00，讨论业绩及运营要点。参与者可拨打美国免费电话 1-844-481-2916，或从其他地区拨打 1-412-317-0709。公司投资者关系页面的 Presentation & Events 将提供现场网络广播及相关材料，网络广播的重播将于11月4日稍后发布。
- None.
- None.
CLEVELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the third-quarter ended September 30, 2025 before the market opens on Tuesday, November 4, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s financial results and operating highlights.
To participate in the live call, please dial 1-844-481-2916 (toll-free in the United States), or 1-412-317-0709 if dialing-in from other locations. A live webcast of the conference call will be accessible at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health, along with the accompanying materials. A replay of the webcast will be available on the Company’s website later in the day on November 4th.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
Source: Sotera Health Company
Contacts
Jason Peterson
Vice President, Investor Relations & Treasurer
IR@soterahealth.com
Kristin Gibbs
Chief Marketing Officer, Sotera Health
kgibbs@soterahealth.com
FAQ
When will Sotera Health (SHC) release Q3 2025 earnings?
What time is the Sotera Health (SHC) Q3 2025 earnings call on November 4?
How can investors join the Sotera Health (SHC) Q3 2025 conference call?
Where can I find the Sotera Health (SHC) Q3 2025 webcast and presentation materials?
Will Sotera Health (SHC) provide a replay of the Q3 2025 webcast?
What period does Sotera Health's Q3 2025 earnings release cover?
